Literature DB >> 7525501

Prognostic value of beta human chorionic gonadotrophin in blood serum of patients with urinary bladder tumours.

Z F Dobrowolski1, B Byrska, M Dolezal.   

Abstract

Beta human chorionic gonadotrophin levels have been assessed in blood serum of 79 patients with bladder tumours before and seven days after transurethral electroresection (TUR). With the growth grade of anaplasia and staging the mean serum beta HCG level increased. Beta HCG was a good biological marker to differentiate between superficial and deep tumours.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7525501     DOI： 10.1007/bf02768213

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  11 in total

Review 1.  Human chorionic gonadotropin expression by bladder cancers: biology and clinical potential.

Authors:  R K Iles; T Chard
Journal:  J Urol       Date:  1991-03       Impact factor: 7.450

2.  Primary chorionepithelioma of the urinary bladder in a male: Report of a case.

Authors:  T Weinberg
Journal:  Am J Pathol       Date:  1939-11       Impact factor: 4.307

3.  Carcinoembryonic antigen and beta-human chorionic gonadotropin as serum markers for advanced urothelial malignancies.

Authors:  F Dexeus; C Logothetis; E Hossan; M L Samuels
Journal:  J Urol       Date:  1986-08       Impact factor: 7.450

4.  Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer.

Authors:  R K Iles; B J Jenkins; R T Oliver; J P Blandy; T Chard
Journal:  Br J Urol       Date:  1989-09

5.  Composition of intact hormone and free subunits in the human chorionic gonadotrophin-like material found in serum and urine of patients with carcinoma of the bladder.

Authors:  R K Iles; C L Lee; R T Oliver; T Chard
Journal:  Clin Endocrinol (Oxf)       Date:  1990-09       Impact factor: 3.478

6.  Human chorionic gonadotropin detected in urinary concentrates from patients with malignant tumors of the testis, prostate, bladder, ureter and kidney.

Authors:  K Fukutani; J M Libby; W B Panko; P T Scardino
Journal:  J Urol       Date:  1983-01       Impact factor: 7.450

7.  Prospective study of the alpha and beta subunits of human chorionic gonadotrophin in the blood of patients with various benign and malignant conditions.

Authors:  M Dosogne-Guérin; A Stolarczyk; A Borkowski
Journal:  Eur J Cancer       Date:  1978-05       Impact factor: 9.162

8.  Immunohistochemical localization and chromatographic characterization of human chorionic gonadotropin in a bladder carcinoma.

Authors:  C J Rodenburg; A C Nieuwenhuyzen Kruseman; H A de Maaker; G J Fleuren; A T van Oosterom
Journal:  Arch Pathol Lab Med       Date:  1985-11       Impact factor: 5.534

9.  Ectopic production of human chorionic gonadotropin by poorly differentiated transitional cell tumors of the urinary tract.

Authors:  R S Wurzel; H T Yamase; P T Nieh
Journal:  J Urol       Date:  1987-03       Impact factor: 7.450

10.  Is ectopic production of human chorionic gonadotrophin (hCG) or alpha fetoprotein (AFP) by tumours a marker of chemosensitivity?

Authors:  S M Crawford; J A Ledermann; W Turkie; G J Rustin; R H Begent; E S Newlands; K D Bagshawe
Journal:  Eur J Cancer Clin Oncol       Date:  1986-12
View more
  3 in total

1.  Gynaecomastia: an unusual presenting symptom of bladder cancer.

Authors:  Mashrafi Ahmed; Aleem Kanji; Tahmina Begum
Journal:  BMJ Case Rep       Date:  2015-06-25

2.  The expression of beta human chorionic gonadotrophin (β-HCG) in human urothelial carcinoma.

Authors:  Anthony Kodzo-Grey Venyo; David Herring; Harold Greenwood; Douglas John Lindsay Maloney
Journal:  Pan Afr Med J       Date:  2010-12-16

3.  Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract.

Authors:  J Douglas; A Sharp; C Chau; J Head; T Drake; M Wheater; T Geldart; G Mead; S J Crabb
Journal:  Br J Cancer       Date:  2014-02-20       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.